EC Healthcare

SEHK:2138 Rapport sur les actions

Capitalisation boursière : HK$948.2m

EC Healthcare Gestion

Gestion contrôle des critères 3/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Leslie Lu

Directeur général

HK$4.8m

Rémunération totale

Pourcentage du salaire du PDG99.6%
Durée du mandat du directeur généralless than a year
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction2.3yrs
Durée moyenne du mandat des membres du conseil d'administration8.7yrs

Mises à jour récentes de la gestion

Recent updates

Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

Sep 05
Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

Jul 26
EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement

May 13
EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement

When Should You Buy EC Healthcare (HKG:2138)?

Apr 26
When Should You Buy EC Healthcare (HKG:2138)?

Is EC Healthcare (HKG:2138) A Risky Investment?

Feb 07
Is EC Healthcare (HKG:2138) A Risky Investment?

Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

Dec 24
Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

Dec 08
EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

Dec 01
Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

Sep 15
At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Aug 24
EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Is EC Healthcare (HKG:2138) Using Too Much Debt?

Aug 10
Is EC Healthcare (HKG:2138) Using Too Much Debt?

EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

Jul 14
EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Jun 26
EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Is There Now An Opportunity In EC Healthcare (HKG:2138)?

Jun 15
Is There Now An Opportunity In EC Healthcare (HKG:2138)?

Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

May 12
Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

Is EC Healthcare (HKG:2138) Potentially Undervalued?

Mar 08
Is EC Healthcare (HKG:2138) Potentially Undervalued?

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Feb 03
EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Dec 20
EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

Oct 25
Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return

Sep 20
EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Sep 01
EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 28
EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Jul 14
EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042

Jun 26
EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042

When Should You Buy EC Healthcare (HKG:2138)?

May 26
When Should You Buy EC Healthcare (HKG:2138)?

EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around

Apr 18
EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?

Feb 24
Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?

EC Healthcare (HKG:2138) Could Easily Take On More Debt

Feb 11
EC Healthcare (HKG:2138) Could Easily Take On More Debt

EC Healthcare (HKG:2138) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Dec 26
EC Healthcare (HKG:2138) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

EC Healthcare Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Dec 02
EC Healthcare Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Analyse de la rémunération des PDG

Comment la rémunération de Leslie Lu a-t-elle évolué par rapport aux bénéfices de EC Healthcare?
DateRémunération totaleSalaireBénéfices de l'entreprise
Mar 31 2024HK$5mHK$5m

-HK$19m

Dec 31 2023n/an/a

-HK$11m

Sep 30 2023n/an/a

-HK$4m

Jun 30 2023n/an/a

HK$33m

Mar 31 2023HK$21mHK$4m

HK$70m

Dec 31 2022n/an/a

HK$93m

Sep 30 2022n/an/a

HK$117m

Jun 30 2022n/an/a

HK$157m

Mar 31 2022HK$13mHK$2m

HK$198m

Rémunération vs marché: La rémunération totale de Leslie ($USD 618.50K ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 371.52K ).

Rémunération et revenus: La rémunération de Leslie a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Leslie Lu (44 yo)

less than a year

Titularisation

HK$4,818,000

Compensation

Mr. Lyn Wade Lu, also known as Leslie, served as Co-Chief Executive Officer & Executive Director at EC Healthcare since August 23, 2021 until November 1, 2023. He serves as Chief Executive Officer at EC He...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Chi Fai Tang
Founder & Executive Chairman8.9yrsHK$1.24m60.93%
HK$ 577.8m
Lyn Wade Lu
Chief Executive Officer & Executive Directorless than a yearHK$4.82mpas de données
Heung Wing Lee
CFO & Executive Director5.3yrsHK$3.77m0.057%
HK$ 544.4k
Tai Cheung Wong
Chief Operating Officer2.3yrspas de donnéespas de données
Kelly Tsang
Associate Director of Accountingno datapas de donnéespas de données
Kin Keung Chan
Chief Public Affairs Officer & Chief Dental Officer2.3yrspas de donnéespas de données
Katy Ip
Sales Directorno datapas de donnéespas de données
Chun Pu Chu
Chief Business Officer4.1yrspas de donnéespas de données
Chun Yu Chan
Chief Talent Officer2.3yrspas de donnéespas de données
Julie Chow
Chief Proposition Officer of Healthcare1.8yrspas de donnéespas de données
Chun Pong Siu
Company Secretary7.1yrspas de donnéespas de données

2.3yrs

Durée moyenne de l'emploi

45yo

Âge moyen

Gestion expérimentée: L'équipe de direction de 2138 est considérée comme expérimentée (ancienneté moyenne 2.1 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Chi Fai Tang
Founder & Executive Chairman8.9yrsHK$1.24m60.93%
HK$ 577.8m
Lyn Wade Lu
Chief Executive Officer & Executive Director3.2yrsHK$4.82mpas de données
Heung Wing Lee
CFO & Executive Director4.8yrsHK$3.77m0.057%
HK$ 544.4k
Ching Nam Ma
Independent Non-Executive Director8.7yrsHK$240.00k0.025%
HK$ 240.0k
Andrew Look
Independent Non-Executive Director8.7yrsHK$220.00kpas de données
Kun Shing Luk
Non Executive Director9.1yrsHK$126.00k0.24%
HK$ 2.3m
Tsun Au
Independent Non-Executive Director2.1yrsHK$120.00kpas de données

8.7yrs

Durée moyenne de l'emploi

44yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 2138 sont considérés comme expérimentés (ancienneté moyenne 8.5 ans).